{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T20:14:06Z","timestamp":1792700046297,"version":"4.5.0"},"reference-count":26,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,6,13]],"date-time":"2025-06-13T00:00:00Z","timestamp":1749772800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:p>A series of 2H-benzo[b][1,4] oxazin-3(4H)-one derivatives linked to 1,2,3-triazoles were designed, synthesized, and evaluated for their anticancer activity in several human cancer cell lines, including A549 (lung), Huh7 (liver), MCF-7 (breast), HCT-116 (colon), and SKOV3 (ovary). Cell viability assays revealed that these compounds exhibited the most potent activity against A549 cells. Among them, compounds 14b and 14c demonstrated the strongest inhibitory effects, with IC<jats:sub>50<\/jats:sub> values of 7.59 \u00b1 0.31\u00a0\u03bcM and 18.52 \u00b1 0.59\u00a0\u03bcM, respectively. Flow cytometry analysis further confirmed that compounds 14b and 14c induced significant apoptosis. Additional studies showed that these compounds elevated reactive oxygen species (ROS) levels, which may contribute to apoptosis. Moreover, compounds 14b and 14c notably increased the number of dead cells while reducing viable cell counts. Western blot analysis indicated that these compounds could induce DNA damage and autophagy, which may play a key role in their anticancer effects.<\/jats:p>","DOI":"10.3389\/fphar.2025.1565657","type":"journal-article","created":{"date-parts":[[2025,6,13]],"date-time":"2025-06-13T05:49:35Z","timestamp":1749793775000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Mechanistic Insights and Anti-cancer Activity of 2H-benzo[b][1,4]oxazin-3(4H)-one Linked 1,2,3-Triazoles in Human Cancer Cells"],"prefix":"10.3389","volume":"16","author":[{"given":"Qingying","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xixi","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingyue","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baoyu","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingjing","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yajie","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianxue","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,6,13]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1626","DOI":"10.1021\/op300185s","article-title":"Identification and development of an efficient route to SB-649915","volume":"16","author":"Armitage","year":"2012","journal-title":"Org. Process Res. Dev."},{"key":"B2","doi-asserted-by":"publisher","first-page":"5481","DOI":"10.1016\/j.bmcl.2017.10.044","article-title":"Potential anti-proliferative agents from 1,4-benzoxazinone-quinazolin-4(3H)-one templates","volume":"27","author":"Bollu","year":"2017","journal-title":"Bioorg Med. Chem. Lett."},{"key":"B3","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1007\/BF01018788","article-title":"Toxicity and toxicokinetics of 6-methoxybenzoxazolinone (MBOA) in the european corn borer,Ostrinia nubilalis (H\u00fcbner)","volume":"14","author":"Campos","year":"1988","journal-title":"J. Chem. Ecol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"107437","DOI":"10.1016\/j.bioorg.2024.107437","article-title":"Novel quinazolin-2-yl 1,2,3-triazole hybrids as promising multi-target anticancer agents: design, synthesis, and molecular docking study","volume":"148","author":"El Hamaky","year":"2024","journal-title":"Bioorg Chem."},{"key":"B5","doi-asserted-by":"publisher","first-page":"831","DOI":"10.3390\/cancers16040831","article-title":"Artificial intelligence-based treatment decisions: a new era for nsclc","volume":"16","author":"Fiste","year":"2024","journal-title":"Cancers"},{"key":"B6","doi-asserted-by":"publisher","first-page":"7788","DOI":"10.1021\/acs.jmedchem.4c00652","article-title":"Triazoles in medicinal Chemistry: physicochemical properties, bioisosterism, and application","volume":"67","author":"Guan","year":"2024","journal-title":"J. Med. Chem."},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1002\/chin.199124055","article-title":"ChemInform abstract: a multi-centered electrophile formed from a unique bioactive cyclic hydroxamic acid, 4-Hydroxy-7-methoxy-2H-1,4-benzoxazin-3(4H)-one","volume":"22","author":"Hashimoto","year":"1991","journal-title":"ChemInform"},{"key":"B8","doi-asserted-by":"publisher","first-page":"5983","DOI":"10.1016\/j.bmc.2013.07.043","article-title":"Design, synthesis, and structure-activity relationships of dihydrofuran-2-one and dihydropyrrol-2-one derivatives as novel benzoxazin-3-one-based mineralocorticoid receptor antagonists","volume":"21","author":"Hasui","year":"2013","journal-title":"Bioorg Med. Chem."},{"key":"B9","doi-asserted-by":"publisher","first-page":"1509520","DOI":"10.3389\/fphar.2024.1509520","article-title":"Design, synthesis, and anti-inflammatory activity of 2H-1,4-benzoxazin-3(4H)-one derivatives modified with 1,2,3-triazole in LPS-induced BV-2 cells","volume":"15","author":"Hou","year":"2024","journal-title":"Front. Pharmacol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1222825","DOI":"10.3389\/fchem.2023.1222825","article-title":"Synthesis and activity study of novel N,N-diphenylurea derivatives as Ido1 inhibitors","volume":"11","author":"Hou","year":"2023","journal-title":"Front. Chem."},{"key":"B11","doi-asserted-by":"publisher","first-page":"3499","DOI":"10.1016\/j.bmc.2015.04.031","article-title":"Synthesis, topoisomerase I and II inhibitory activity, cytotoxicity, and structure-activity relationship study of 2-phenyl- or hydroxylated 2-phenyl-4-aryl-5H-indeno[1,2-b]pyridines","volume":"22","author":"Kadayat","year":"2015","journal-title":"Bioorg. and Med. Chem."},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1080\/03601234.2016.1142744","article-title":"Synthesis and antifungal activity of 2H-1,4-benzoxazin-3(4H)-one derivatives","author":"Kwiecien","year":"2016","journal-title":"J. Environ. Sci. and Health Part B Pesticides Food Contam. and Agric. Wastes"},{"key":"B13","doi-asserted-by":"publisher","first-page":"225","DOI":"10.21608\/ejchem.2019.16920.2030","article-title":"Synthesis, antimicrobial, antioxidant and docking study of novel 2H-1,4-Benzoxazin-3(4H)-One derivatives","volume":"63","author":"Mhmood","year":"2019","journal-title":"Egypt. J. Chem."},{"key":"B14","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.1080\/14756366.2022.2072308","article-title":"New 1,2,3-triazole linked ciprofloxacin-chalcones induce DNA damage by inhibiting human topoisomerase I& II and tubulin polymerization","volume":"37","author":"Mohammed","year":"2022","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"B15","doi-asserted-by":"publisher","first-page":"4887","DOI":"10.1016\/j.ejmech.2011.07.045","article-title":"Synthesis and pharmacological evaluations of novel 2H-benzo[b] [1,4]oxazin-3(4H)-one derivatives as a new class of anti-cancer agents","volume":"46","author":"Rajitha","year":"2011","journal-title":"Eur. J. Med. Chem."},{"key":"B16","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.3987\/r-1983-08-1481","article-title":"Reaction of 4Acetoxy1,4-benzoxazin-3-one with amino acid derivatives","volume":"20","author":"Shudo","year":"1983","journal-title":"Heterocycles"},{"key":"B17","doi-asserted-by":"publisher","first-page":"131747","DOI":"10.1016\/j.molstruc.2021.131747","article-title":"Synthesis of fused 1,2,3-triazoles of Clioquinol via sequential CuAAC and C H arylation; in vitro anticancer activity, in silico DNA topoisomerase II inhibitory activity and ADMET","volume":"1250","author":"Srinivas Reddy","year":"2022","journal-title":"J. Mol. Struct."},{"key":"B18","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1021\/ml900022q","article-title":"NH-1,2,3-Triazole-based inhibitors of the VIM-2 metallo-\u03b2-lactamase: synthesis and structure-activity studies","volume":"1","author":"Weide","year":"2010","journal-title":"Acs Med. Chem. Lett."},{"key":"B26","doi-asserted-by":"crossref","first-page":"10630","DOI":"10.1093\/nar\/gkt828","article-title":"On the structural basis and design guidelines for type II topoisomerase-targeting anticancer drugs","volume":"41","author":"Wu","year":"2013","journal-title":"Nucleic Acids Res."},{"key":"B19","doi-asserted-by":"publisher","first-page":"1265289","DOI":"10.3389\/fphar.2023.1265289","article-title":"Design and synthesis of cabotegravir derivatives bearing 1,2,3-triazole and evaluation of anti-liver cancer activity","volume":"14","author":"Xie","year":"2023","journal-title":"Front. Pharmacol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1016\/j.ejmech.2019.06.021","article-title":"Discovery of 4-phenyl-2H-benzo[b] [1,4]oxazin-3(4H)-one derivatives as potent and orally active PI3K\/mTOR dual inhibitors","volume":"178","author":"Yan","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"B21","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1039\/c4md00031e","article-title":"Synthesis and biological evaluation of coumarin\u20131,2,3-triazole\u2013dithiocarbamate hybrids as potent LSD1 inhibitors","volume":"5","author":"Ye","year":"2014","journal-title":"MedChemComm"},{"key":"B22","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.ejmech.2012.12.046","article-title":"Design and synthesis of novel 1,2,3-triazole-dithiocarbamate hybrids as potential anticancer agents","volume":"62","author":"Ying-Chao","year":"2013","journal-title":"Eur. J. Med. Chem."},{"key":"B23","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1080\/10406638.2019.1584575","article-title":"Docking, synthesis, antifungal and cytotoxic activities of some novel substituted 4H-Benzoxazin-3-one","volume":"41","author":"Zamani","year":"2021","journal-title":"Polycycl. Aromat. Compd."},{"key":"B24","doi-asserted-by":"publisher","first-page":"106926","DOI":"10.1016\/j.bioorg.2023.106926","article-title":"Discovery of dolutegravir-1,2,3-triazole derivatives against prostate cancer via inducing DNA damage","volume":"141","author":"Zhou","year":"2023","journal-title":"Bioorg Chem."},{"key":"B25","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.ejmech.2014.03.087","article-title":"Synthesis of 6-cinnamoyl-2H-benzo[b] [1,4]oxazin-3(4H)-ones and their effects on A549 lung cancer cell growth","volume":"79","author":"Zhou","year":"2014","journal-title":"Eur. J. Med. Chem."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2025.1565657\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,13]],"date-time":"2025-06-13T05:49:36Z","timestamp":1749793776000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2025.1565657\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,13]]},"references-count":26,"alternative-id":["10.3389\/fphar.2025.1565657"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2025.1565657","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,13]]},"article-number":"1565657"}}